Liang-Ru Ke

The CXCL5/CXCR2 axis contributes to the epithelial-mesenchymal transition of nasopharyngeal carcinoma cells by activating ERK/GSK-3β/snail signalling

Wen‐Ze Qiu, Haibo Zhang, Wei-Xiong Xia et al. · Journal of Experimental & Clinical Cancer Research · 2018 · 59 citations · Full text

Medicine, Molecular Biology, Oncology +17

Survival impact of waiting time for radical radiotherapy in nasopharyngeal carcinoma: A large institution-based cohort study from an endemic area

Yan‐Qun Xiang, Xing Lv, Chang-Qing Xie et al. · European Journal of Cancer · 2017 · 49 citations

Medicine, Oncology, Radiation Oncology +11

Combining cetuximab with chemoradiotherapy in patients with locally advanced nasopharyngeal carcinoma: A propensity score analysis

Wei-Xiong Xia, Xing Lv, Lin Wang et al. · Oral Oncology · 2017 · 31 citations

Medicine, Oncology, Pharmacotherapy +12

Nab-paclitaxel, cisplatin, and capecitabine versus cisplatin and gemcitabine as first line chemotherapy in patients with recurrent or metastatic nasopharyngeal carcinoma: randomised phase 3 clinical trial

Guoying Liu, Yan-Fang Ye, Yao-Fei Jiang et al. · BMJ · 2024 · 16 citations · Full text

Medicine, Oncology, Pharmacology +17

Concurrent Chemoradiotherapy versus Intensity-modulated Radiotherapy Alone for Elderly Nasopharyngeal Carcinoma Patients with Pre-treatment Epstein-Barr Virus DNA: A Cohort Study in an Endemic Area with Long-term Follow-up

Qin Yang, TingTing Zhao, Meng-Yun Qiang et al. · Journal of Cancer · 2018 · 13 citations · Full text

Medicine, Oncology, Radiation Oncology +14